Literature DB >> 17953248

Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease.

Ancha Baranova1, Karen Schlauch, Hazem Elariny, Mohammed Jarrar, Chase Bennett, Clare Nugent, Shobha J Gowder, Zahra Younoszai, Rochelle Collantes, Vikas Chandhoke, Zobair M Younossi.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) and its progressive form, non-alcoholic steatohepatitis (NASH), are among the least understood metabolic consequences of obesity. Increasingly, omental adipose tissue is recognized as a biologically active organ in the pathogenesis of NAFLD. Differences in transcriptional regulation in omental adipose tissue and liver tissue may provide important insights into the pathogenesis of NAFLD and its progression.
METHODS: Transcriptional profiles were obtained for liver and visceral adipose specimens of morbidly obese patients undergoing bariatric surgery. Functional analyses with the Ingenuity Pathways Knowledge Base (IPKB) and IPA 4.0 software identified genes that potentially play hepatoprotective roles as well as those potentially involved in the pathogenesis of NASH. TNFalpha and IL6 were measured in the serum samples.
RESULTS: Tissue from patients with NASH showed prominent adipose-specific deregulation of genes related to inflammation and the immune system. A number of liver and adipose-specific functional networks, including those centered at TNFalpha, JUN/JUNB, and IFNgamma were highlighted as related to the NASH pathogenesis. The results also showed compensatory increases in hepatic detoxification enzymes and decreases in the gene network controlled by transcription factor COUP-TFII.
CONCLUSION: Our findings support the hypothesis that adipocyte secretion plays an important role in the development of NAFLD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17953248     DOI: 10.1007/s11695-007-9187-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  29 in total

Review 1.  Nonalcoholic fatty liver disease: an agenda for clinical research.

Authors:  Zobair M Younossi; Anna Mae Diehl; Janus P Ong
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

Review 2.  Medical consequences of obesity.

Authors:  George A Bray
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

3.  A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease.

Authors:  Zobair M Younossi; Ancha Baranova; Katharine Ziegler; Luca Del Giacco; Karen Schlauch; Timothy L Born; Hazem Elariny; Francesco Gorreta; Amy VanMeter; Abraham Younoszai; Janus P Ong; Zachary Goodman; Vikas Chandhoke
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

4.  Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C.

Authors:  Katia Falasca; Claudio Ucciferri; Margherita Dalessandro; Pompea Zingariello; Paola Mancino; Claudia Petrarca; Eligio Pizzigallo; Pio Conti; Jacopo Vecchiet
Journal:  Ann Clin Lab Sci       Date:  2006       Impact factor: 1.256

5.  Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease.

Authors:  Jaime Poniachik; Attila Csendes; Juan C Díaz; Jorge Rojas; Patricio Burdiles; Fernando Maluenda; Gladys Smok; Ramón Rodrigo; Luis A Videla
Journal:  Cytokine       Date:  2006-03-27       Impact factor: 3.861

Review 6.  Etiopathogenesis of nonalcoholic steatohepatitis.

Authors:  S Chitturi; G C Farrell
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

7.  Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.

Authors:  Ancha Baranova; Shobha J Gowder; Karen Schlauch; Hazem Elariny; Rochelle Collantes; Arian Afendy; Janus P Ong; Zachary Goodman; Vikas Chandhoke; Zobair M Younossi
Journal:  Obes Surg       Date:  2006-09       Impact factor: 4.129

Review 8.  Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.

Authors:  Andreas Schäffler; Jürgen Schölmerich; Christa Büchler
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-06

9.  The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action.

Authors:  Dirk E Smith; Roberta Hanna; Heather Moore; Hongbo Chen; Ann M Farese; Thomas J MacVittie; G Duke Virca; John E Sims
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

10.  Non-alcoholic steatohepatitis: review of a growing medical problem.

Authors:  K. Te Sligte; I. Bourass; J.P. Sels; A. Driessen; R.W. Stockbrugger; G.H. Koek
Journal:  Eur J Intern Med       Date:  2004-02       Impact factor: 4.487

View more
  13 in total

1.  Time-dependent network analysis reveals molecular targets underlying the development of diet-induced obesity and non-alcoholic steatohepatitis.

Authors:  Hea-Young Oh; Su-Kyung Shin; Hyoung-Sam Heo; Ji-Sook Ahn; Eun-Young Kwon; Jung Han Yoon Park; Yun-Young Cho; Hae-Jin Park; Mi-Kyung Lee; Eun Jung Kim; Un-Ju Jung; Robin A McGregor; Cheol-Goo Hur; Myung-Sook Choi
Journal:  Genes Nutr       Date:  2012-11-13       Impact factor: 5.523

Review 2.  CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).

Authors:  Sonia M Najjar; Lucia Russo
Journal:  Semin Immunopathol       Date:  2013-11-21       Impact factor: 9.623

3.  Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.

Authors:  J Latorre; J M Moreno-Navarrete; J M Mercader; M Sabater; Ò Rovira; J Gironès; W Ricart; J M Fernández-Real; F J Ortega
Journal:  Int J Obes (Lond)       Date:  2017-01-25       Impact factor: 5.095

Review 4.  Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis.

Authors:  Ryutaro Kuraji; Satoshi Sekino; Yvonne Kapila; Yukihiro Numabe
Journal:  Periodontol 2000       Date:  2021-10       Impact factor: 7.589

5.  Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis.

Authors:  J Michael Estep; Ancha Baranova; Noreen Hossain; Hazem Elariny; Kathy Ankrah; Arian Afendy; Vikas Chandhoke; Zobair M Younossi
Journal:  Obes Surg       Date:  2009-03-12       Impact factor: 4.129

6.  Exploration of a symptoms experience in people with obesity-related nonalcoholic fatty liver disease.

Authors:  Lori D Houghton-Rahrig; Debra L Schutte; Alexander von Eye; Jenifer I Fenton; Barbara A Given; Norman G Hord
Journal:  Nurs Outlook       Date:  2013 Jul-Aug       Impact factor: 3.250

7.  Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease.

Authors:  April D Lake; Petr Novak; Craig D Fisher; Jonathan P Jackson; Rhiannon N Hardwick; D Dean Billheimer; Walter T Klimecki; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2011-07-07       Impact factor: 3.922

8.  Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients.

Authors:  Adeline Bertola; Stéphanie Bonnafous; Rodolphe Anty; Stéphanie Patouraux; Marie-Christine Saint-Paul; Antonio Iannelli; Jean Gugenheim; Jonathan Barr; José M Mato; Yannick Le Marchand-Brustel; Albert Tran; Philippe Gual
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

9.  Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease.

Authors:  Rohini Mehta; Aybike Birerdinc; Lei Wang; Zahra Younoszai; Amir Moazzez; Hazem Elariny; Zachary Goodman; Vikas Chandhoke; Ancha Baranova; Zobair M Younossi
Journal:  BMC Gastroenterol       Date:  2014-04-09       Impact factor: 3.067

Review 10.  Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome.

Authors:  Patrick Wainwright; Christopher D Byrne
Journal:  Int J Mol Sci       Date:  2016-03-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.